LifeSensors Tandem Ubiquitin Binding Entity (TUBEs)

Friday, 02 August, 2013 | Supplied by: United Bioresearch Products Pty Ltd

LifeSensors Tandem Ubiquitin Binding Entity (TUBEs)

Tandem Ubiquitin Binding Entities (TUBEs) are high-affinity ‘ubiquitin traps’ that bind polyubiquitin chains. LifeSensors has developed TUBE technology for the detection, characterisation and isolation of polyubiquitylated proteins from cells and tissue extracts.

TUBEs have 100- to 1000-fold higher affinity for polyubiquitin chains compared to monomer ubiquitin binding domains (UBDs). They both stabilise and bind to ubiquitylated proteins, serving as a suitable tool for ubiquitologists.

The versatile collection includes reagents for isolation/pulldown of polyubiquitin conjugates (Agarose-TUBEs, GST- and His6-TUBEs). For immunohistochemistry, use Fluorescent TUBEs conjugated to either fluorescein or TAMRA. Use Biotin-TUBEs for the detection of polyubiquitylated proteins by ligand blotting.

Biotin-K63 TUBE 1 displays a high sensitivity and specificity for polyubiquitin chains linked through K63. It is said to be more sensitive and cost-effective for the detection of K63-linked polyubiquitylated proteins compared to a traditional Western blot using chain-specific antibodies. It is suitable for ligand blotting, affinity purification from lysates and biological fluids, and in situ detection.

Other claimed features of the TUBEs include: high binding capacity for pull-downs; higher specificity than antibodies and UBAs; lower cost per experiment.

Online: www.unitedbioresearch.com.au
Phone: 02 4575 0309
Related Products

Enzo Life Sciences PROTEOSTAT Protein refolding and aggregation sensing kit

The kit includes a comprehensive set of optimised screening reagents and conditions that...

Bio-Rad Laboratories ddPLEX ESR1 Mutation Detection Kit

The kit enables simultaneous detection, discrimination and absolute quantification of seven known...

AdipoGen Life Sciences InVivoKines recombinant fusion proteins

InVivoKines are recombinant fusion proteins for immunotherapeutic, preclinical and translational...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd